TOKYO & BOSTON--(BUSINESS WIRE)--Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation ...
Hosted on MSN1mon
Bain Capital to Buy Mitsubishi Chemical’s Pharma Business for More Than $3 BillionBain Capital has agreed to acquire Mitsubishi ... The U.S. investment company said Friday that it will buy Mitsubishi Tanabe Pharma for about 510 billion yen, equivalent to $3.37 billion.
US investment group Bain Capital has agreed to buy Mitsubishi Tanabe Pharma for JPY 510 billion (around $3.4 billion), setting up one of the largest private equity buyouts in Japan's healthcare ...
The firm acts on some of Japan’s most prominent transactions, including Bain Capital's $3.3 billion pharma acquisition of ...
February 7, 2025 Bain to buy Japan's Mitsubishi Tanabe Pharma for $3.4 billion U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results